These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1496661)

  • 1. Usefulness of protein-restricted diet and recombinant human erythropoietin in patients with chronic rejection of a transplanted kidney.
    Sanaka T; Takahashi K; Teraoka S; Toma H; Agishi T; Sugino N; Ota K
    Transplant Proc; 1992 Aug; 24(4):1571-2. PubMed ID: 1496661
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of renal transplantation in patients treated with erythropoietin.
    Linde T; Wahlberg J; Wikström B; Danielson BG
    Clin Nephrol; 1992 May; 37(5):260-3. PubMed ID: 1606776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
    Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
    Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to rHuEpo and kidney graft rejection.
    Page B; Zingraff J
    Nephrol Dial Transplant; 1994; 9(11):1696. PubMed ID: 7870369
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic effect of a high-protein low-fat diet in transplant patients.
    Borges W; González Caraballo Z; Delpín EA; Morales Otero L
    Transplant Proc; 1996 Dec; 28(6):3400-1. PubMed ID: 8962328
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
    Kokot F; Wiecek A; Grzeszczak W; Lao M; Kuśmierski S; Cierpka L; Gradowska L; Jagiełło R
    Transplant Proc; 1996 Dec; 28(6):3477-9. PubMed ID: 8962352
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
    Grimm PC; Sekiya NM; Robertson LS; Robinson BJ; Ettenger RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hematologic findings and value of value of endogenous creatinine in patients following kidney transplantation].
    Zadrazil J; Bachleda P; Krejcí K
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():103-6. PubMed ID: 10743736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia following renal transplantation: erythropoietin response and iron deficiency.
    Miles AM; Markell MS; Daskalakis P; Sumrani NB; Hong J; Sommer BG; Friedman EA
    Clin Transplant; 1997 Aug; 11(4):313-5. PubMed ID: 9267720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skew in T-cell receptor usage and clonal T-cell expansion in patients with chronic rejection of transplanted kidneys.
    Matsutani T; Ohashi Y; Yoshioka T; Tsuruta Y; Doi H; Satomi S; Suzuki R
    Transplantation; 2003 Feb; 75(3):398-407. PubMed ID: 12589165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
    Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and renin levels in human renal allotransplant patients.
    Murphy GP; Mirand EA; Williams PD
    J Med; 1971; 2(4):217-27. PubMed ID: 4946630
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine therapy or dietary protein manipulation in chronic renal allograft rejection.
    Kootte AM; Paul LC
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):821-6. PubMed ID: 3291321
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum erythropoietin levels after renal transplantation with various graft outcomes.
    Ghods AJ; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2577-8. PubMed ID: 7482834
    [No Abstract]   [Full Text] [Related]  

  • 15. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
    Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
    Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin and renal transplantation. The Canadian Erythropoietin Study Group.
    Keown PA
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):52-8. PubMed ID: 2192417
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of cadaveric renal allograft recipients developing chronic rejection.
    Foster MC; Rowe PA; Dennis MJ; Morgan AG; Burden RP; Blamey RW
    Ann R Coll Surg Engl; 1990 Jan; 72(1):23-6. PubMed ID: 2301899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary protein and the renin-angiotensin system in chronic renal allograft rejection.
    Rosenberg ME; Salahudeen AK; Hostetter TH
    Kidney Int Suppl; 1995 Dec; 52():S102-6. PubMed ID: 8587269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.